GENE ONLINE|News &
Opinion
Blog

M&A
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Kriya Scoops Up Redpin to Break into Neurology Gene Therapies
2022-11-16
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
Myovant Turns Down $2.4 Billion Buyout Bid From Sumitomo
2022-10-03
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
CVS Beats Amazon in Signify Bidding War with $8 Billion Acquisition Offer
2022-09-06
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
Novartis Split: Sandoz Spin Off Forming A Standalone Company
2022-08-25
1 2 3 4 12
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top